Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach.
Kong SH, Kurokawa Y, Yook JH, Cho H, Kwon OK, Masuzawa T, Lee KH, Matsumoto S, Park YS, Honda H, Ryu SW, Ishikawa T, Kang HJ, Nabeshima K, Im SA, Shimokawa T, Kang YK, Hirota S, Yang HK, Nishida T.
Kong SH, et al. Among authors: yook jh.
Gastric Cancer. 2023 Sep;26(5):775-787. doi: 10.1007/s10120-023-01406-0. Epub 2023 Jun 23.
Gastric Cancer. 2023.
PMID: 37351703
Clinical Trial.